# Ames National Corp: financial statements, quarterly

ATLO · Nasdaq · CIK 1132651 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/atlo.md) · [Financials](/companies/atlo/financials.md) · [Filings](/companies/atlo/filings.md) · [Insiders](/companies/atlo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/atlo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [8,073](/filings/0001437749-23-030643.md) | [8,891 d](/filings/0001437749-24-007097.md) | [9,205](/filings/0001437749-24-015359.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [597](/filings/0001437749-24-034149.md) | [340 d](/filings/0001437749-25-007223.md) | [416](/filings/0001437749-25-015713.md) | [385](/filings/0001437749-25-025672.md) | [397](/filings/0001437749-25-033807.md) | [825 d](/filings/0001437749-26-007976.md) | [794](/filings/0001437749-26-015819.md) | [1,125](/filings/0001437749-26-026572.md) | [1,156](/filings/0001437749-25-033807.md) | [1,764 d](/filings/0001437749-26-007976.md) | [1,730](/filings/0001437749-26-015819.md) | [1,777](/filings/0001437749-26-026572.md) |
| Net income | $k | [2,924](/filings/0001437749-24-034149.md) | [2,139 d](/filings/0001437749-25-007223.md) | [2,304](/filings/0001437749-25-015713.md) | [2,184](/filings/0001437749-25-025672.md) | [2,217](/filings/0001437749-25-033807.md) | [3,513 d](/filings/0001437749-26-007976.md) | [3,443](/filings/0001437749-26-015819.md) | [4,511](/filings/0001437749-26-026572.md) | [4,559](/filings/0001437749-25-033807.md) | [6,514 d](/filings/0001437749-26-007976.md) | [5,960](/filings/0001437749-26-015819.md) | [5,931](/filings/0001437749-26-026572.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | [0.33](/filings/0001437749-24-034149.md) | not reported | [0.26](/filings/0001437749-25-015713.md) | [0.24](/filings/0001437749-25-025672.md) | [0.25](/filings/0001437749-25-033807.md) | not reported | [0.39](/filings/0001437749-26-015819.md) | [0.51](/filings/0001437749-26-026572.md) | [0.51](/filings/0001437749-25-033807.md) | not reported | [0.67](/filings/0001437749-26-015819.md) | [0.67](/filings/0001437749-26-026572.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [90.1](/filings/0001437749-23-030643.md) | [55.1](/filings/0001437749-25-007223.md) | [111](/filings/0001437749-24-015359.md) | [63.4](/filings/0001437749-24-025737.md) | [59.0](/filings/0001437749-24-034149.md) | [101](/filings/0001437749-26-007976.md) | [163](/filings/0001437749-25-015713.md) | [95.2](/filings/0001437749-25-025672.md) | [108](/filings/0001437749-25-033807.md) | [127](/filings/0001437749-26-026572.md) | [118](/filings/0001437749-26-015819.md) | [107](/filings/0001437749-26-026572.md) |
| Total assets | $m | [2,154](/filings/0001437749-23-030643.md) | [2,155](/filings/0001437749-25-007223.md) | [2,192](/filings/0001437749-24-015359.md) | [2,126](/filings/0001437749-24-025737.md) | [2,123](/filings/0001437749-24-034149.md) | [2,133](/filings/0001437749-26-007976.md) | [2,184](/filings/0001437749-25-015713.md) | [2,093](/filings/0001437749-25-025672.md) | [2,108](/filings/0001437749-25-033807.md) | [2,134](/filings/0001437749-26-026572.md) | [2,143](/filings/0001437749-26-015819.md) | [2,123](/filings/0001437749-26-026572.md) |
| Total liabilities | $m | [2,007](/filings/0001437749-23-030643.md) | [1,990](/filings/0001437749-25-007223.md) | [2,026](/filings/0001437749-24-015359.md) | [1,959](/filings/0001437749-24-025737.md) | [1,940](/filings/0001437749-24-034149.md) | [1,958](/filings/0001437749-26-007976.md) | [2,001](/filings/0001437749-25-015713.md) | [1,900](/filings/0001437749-25-025672.md) | [1,907](/filings/0001437749-25-033807.md) | [1,926](/filings/0001437749-26-026572.md) | [1,935](/filings/0001437749-26-015819.md) | [1,910](/filings/0001437749-26-026572.md) |
| Long-term debt | $m | not reported | [3.5](/filings/0001437749-24-007097.md) | not reported | not reported | not reported | [20.0](/filings/0001437749-25-007223.md) | not reported | not reported | not reported | [18.4](/filings/0001437749-26-007976.md) | not reported | not reported |
| Shareholders' equity | $m | [147](/filings/0001437749-24-034149.md) | [166](/filings/0001437749-26-007976.md) | [166](/filings/0001437749-25-025672.md) | [167](/filings/0001437749-25-033807.md) | [183](/filings/0001437749-25-033807.md) | [175](/filings/0001437749-26-026572.md) | [183](/filings/0001437749-26-026572.md) | [193](/filings/0001437749-26-026572.md) | [201](/filings/0001437749-25-033807.md) | [208](/filings/0001437749-26-026572.md) | [208](/filings/0001437749-26-026572.md) | [213](/filings/0001437749-26-026572.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [2,341 d](/filings/0001437749-24-034149.md) | [6,393 d](/filings/0001437749-25-007223.md) | [1,368](/filings/0001437749-25-015713.md) | [3,892 d](/filings/0001437749-25-025672.md) | [3,099 d](/filings/0001437749-25-033807.md) | [5,940 d](/filings/0001437749-26-007976.md) | [7,118](/filings/0001437749-26-015819.md) | [4,013 d](/filings/0001437749-26-026572.md) | [2,751 d](/filings/0001437749-25-033807.md) | [7,457 d](/filings/0001437749-26-007976.md) | [8,361](/filings/0001437749-26-015819.md) | [3,436 d](/filings/0001437749-26-026572.md) |
| Capital expenditure | $k | [1,278 d](/filings/0001437749-24-034149.md) | [1,050 d](/filings/0001437749-25-007223.md) | [64.0](/filings/0001437749-25-015713.md) | [100 d](/filings/0001437749-25-025672.md) | [67.0 d](/filings/0001437749-25-033807.md) | [67.0 d](/filings/0001437749-26-007976.md) | [195](/filings/0001437749-26-015819.md) | [115 d](/filings/0001437749-26-026572.md) | [101 d](/filings/0001437749-25-033807.md) | [231 d](/filings/0001437749-26-007976.md) | [405](/filings/0001437749-26-015819.md) | [273 d](/filings/0001437749-26-026572.md) |
| Dividends paid | $k | [2,428 d](/filings/0001437749-24-034149.md) | [2,428 d](/filings/0001437749-25-007223.md) | [2,428](/filings/0001437749-25-015713.md) | [2,428 d](/filings/0001437749-25-025672.md) | [2,428 d](/filings/0001437749-25-033807.md) | [1,798 d](/filings/0001437749-26-007976.md) | [1,782](/filings/0001437749-26-015819.md) | [1,780 d](/filings/0001437749-26-026572.md) | [1,779 d](/filings/0001437749-25-033807.md) | [1,772 d](/filings/0001437749-26-007976.md) | [2,126](/filings/0001437749-26-015819.md) | [2,125 d](/filings/0001437749-26-026572.md) |
| Share repurchases | $k | [0.0 d](/filings/0001437749-23-030643.md) | [0.0 d](/filings/0001437749-25-007223.md) | [0.0](/filings/0001437749-25-015713.md) | [0.0 d](/filings/0001437749-25-025672.md) | [0.0 d](/filings/0001437749-25-033807.md) | [704 d](/filings/0001437749-26-007976.md) | [550](/filings/0001437749-26-015819.md) | [279 d](/filings/0001437749-26-026572.md) | [122 d](/filings/0001437749-25-033807.md) | [733 d](/filings/0001437749-26-007976.md) | [0.0](/filings/0001437749-26-015819.md) | [0.0 d](/filings/0001437749-26-026572.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 8,857,220 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001437749-26-026572.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.